tiprankstipranks
Trending News
More News >
Regencell Bioscience Holdings Ltd. (RGC)
:RGC
US Market

Regencell Bioscience (RGC) Income Statement

Compare
535 Followers

Regencell Bioscience Income Statement

Last quarter (Q2 2025), Regencell Bioscience's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Regencell Bioscience's net income was $-1.85M. See Regencell Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -392.74K$ -745.59K$ -769.69K$ -604.40K$ -26.46K
Operating Expenses
$ 3.38M$ 3.99M$ 6.27M$ 7.62M$ 1.38M
Depreciation and Amortization
$ 392.74K$ 745.59K$ 769.69K$ 604.40K$ 26.46K
EBITDA
$ -3.19M$ -3.62M$ -5.29M$ -6.99M$ -1.35M
Operating Income
$ -3.77M$ -4.74M$ -6.27M$ -7.62M$ -1.38M
Other Income/Expenses
$ 185.77K$ 373.50K$ 211.34K$ 23.21K$ 34.62K
Pretax Income
$ -3.58M$ -4.36M$ -6.06M$ -7.59M$ -1.35M
Net Income
$ -3.58M$ -4.30M$ -5.87M$ -7.42M$ -1.35M
Per Share Metrics
Basic EPS
$ -0.01$ -0.01$ -0.01$ -0.02$ 0.00
Diluted EPS
$ -0.01$ -0.01$ -0.01$ -0.02$ 0.00
Weighted Average Shares Outstanding
494.49M 494.49M 494.49M 494.49M 480.40M
Weighted Average Shares Outstanding (Diluted)
494.49M 494.49M 494.49M 494.49M 480.40M
Currency in USD

Regencell Bioscience Earnings and Revenue History